Premium
Effect of transfer from a pediatric to adult cystic fibrosis center on clinical status and hospital attendance
Author(s) -
Collins Rachel,
Singh Bhajan,
Payne Donald N.,
Bharat Chrianna,
Noffsinger William,
Dhaliwal Satvinder S.,
O'Dea Christopher,
Mulrennan Siobhain
Publication year - 2021
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.25398
Subject(s) - medicine , cystic fibrosis , pediatrics , sputum , medical record , attendance , surgery , tuberculosis , pathology , economics , economic growth
Aim Transfer from pediatric to adult services could lead to clinical deterioration, few studies have examined this. We sought to examine the clinical impact of a structured individualized transition and transfer process in patients with cystic fibrosis (CF). Methods Medical records of all patients with CF in Western Australia who transferred from a pediatric center (Princess Margaret Hospital for Children) to an adult CF center (Sir Charles Gairdner Hospital) between 2008 and 2012 were reviewed. Data were extracted for 2 years before and after transfer. The number of CF outpatient visits, inpatient days, and home intravenous antibiotic therapy (HIVT) days were recorded at yearly intervals before and after transfer. Sputum culture results at transfer were collected. All respiratory function and anthropometric data over the 4 years were extracted. Results Forty‐two patients with CF were transferred between 2008 and 2012. The mean age at transfer was 18.9 years (range 17–22). Compared to 1‐year pre‐transfer, the frequency of outpatient visits at 1‐ and 2‐year post‐transfer increased. After transfer, there was no change in BMI, HIVT days, or inpatient days, and no acceleration in the expected decline in FEV1. Conclusion This study found that transfer from a pediatric to an adult CF center using a structured, individualized transition and transfer process was not associated with accelerated clinical deterioration.